The Government has issued directions to the States and Central Government Health Scheme (CGHS) to accept supply of Ayurveda, Siddha, Unani And Homoeopathy (ASU&H) medicines with batch wise quality analysis from an approved laboratory/NABL accredited Laboratory.
Good Manufacturing Practices for Ayurveda, Siddha and Unani (ASU) drugs has been made mandatory for license of ASU drugs to ensure storage conditions should be free from fungal or bacterial contamination. In-house quality control section is also made mandatory for batch wise testing facility of ASU products.
The Government of India has defined adulterated drugs under section 33 EE (Chapter IV-A) of the Drugs & Cosmetics Act, 1940.
Under Section 33-I, penalties have been prescribed, for manufacture, sale etc. of Ayurvedic, Siddha or Unani drug in contravention of the Act. State Drug Licensing Authorities are empowered to take action accordingly.
Increase in opportunities predicted for high-speed optical transceivers and miniaturized connectivity solutions to address data-intensive…
HONG KONG SAR - Media OutReach Newswire - 23 December 2024 - DYXnet, a wholly-owned…
CAIRO, EGYPT - Media OutReach Newswire - 23 December 2024 - Eand, Novo Nordisk, BSH,…
Trend Vision One™ – Email and Collaboration Security is a critical part of Trend’s centralized…
SINGAPORE - Media OutReach Newswire - 23 December 2024 - Madame Tussauds Singapore is proud…
BANGALORE, INDIA / SINGAPORE - Media OutReach Newswire - 23 December 2024 - GangaGen announced…